Literature DB >> 35394496

Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21.

Christine R Zhang1, Elizabeth L Ostrander1, Ostap Kukhar1, Cates Mallaney1, Jiameng Sun1, Emily Haussler1, Hamza Celik1, Won Kyun Koh1, Katherine Y King2, Paul Gontarz3, Grant A Challen1.   

Abstract

Clonal hematopoiesis (CH) refers to the age-related expansion of specific clones in the blood system, and manifests from somatic mutations acquired in hematopoietic stem cells (HSCs). Most CH variants occur in the gene DNMT3A, but while DNMT3A-mutant CH becomes almost ubiquitous in aging humans, a unifying molecular mechanism to illuminate how DNMT3A-mutant HSCs outcompete their counterparts is lacking. Here, we used interferon gamma (IFNγ) as a model to study the mechanisms by which Dnmt3a mutations increase HSC fitness under hematopoietic stress. We found Dnmt3a-mutant HSCs resist IFNγ-mediated depletion, and IFNγ-signaling is required for clonal expansion of Dnmt3a-mutant HSCs in vivo. Mechanistically, DNA hypomethylation-associated overexpression of Txnip in Dnmt3a-mutant HSCs leads to p53 stabilization and upregulation of p21. This preserves the functional potential of Dnmt3a-mutant HSCs through increased quiescence and resistance to IFNγ-induced apoptosis. These data identify a previously undescribed mechanism to explain increased fitness of DNMT3A-mutant clones under hematopoietic stress. SIGNIFICANCE: DNMT3A mutations are common variants in clonal hematopoiesis, and recurrent events in blood cancers. Yet the mechanisms by which these mutations provide hematopoietic stem cells a competitive advantage as a precursor to malignant transformation remain unclear. Here, we use inflammatory stress to uncover molecular mechanisms leading to this fitness advantage.See related commentary by De Dominici and DeGregori, p. 178. This article is highlighted in the In This Issue feature, p. 171. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35394496      PMCID: PMC9414740          DOI: 10.1158/2643-3230.BCD-21-0132

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN: 2643-3230


  49 in total

1.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

Authors:  Kelly Moran-Crusio; Linsey Reavie; Alan Shih; Omar Abdel-Wahab; Delphine Ndiaye-Lobry; Camille Lobry; Maria E Figueroa; Aparna Vasanthakumar; Jay Patel; Xinyang Zhao; Fabiana Perna; Suveg Pandey; Jozef Madzo; Chunxiao Song; Qing Dai; Chuan He; Sherif Ibrahim; Miloslav Beran; Jiri Zavadil; Stephen D Nimer; Ari Melnick; Lucy A Godley; Iannis Aifantis; Ross L Levine
Journal:  Cancer Cell       Date:  2011-06-30       Impact factor: 31.743

2.  Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients.

Authors:  Christine R C Zhang; Darren Nix; Martin Gregory; Matthew A Ciorba; Elizabeth L Ostrander; Rodney D Newberry; David H Spencer; Grant A Challen
Journal:  Exp Hematol       Date:  2019-12-05       Impact factor: 3.084

3.  Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.

Authors:  Christopher B Cole; David A Russler-Germain; Shamika Ketkar; Angela M Verdoni; Amanda M Smith; Celia V Bangert; Nichole M Helton; Mindy Guo; Jeffery M Klco; Shelly O'Laughlin; Catrina Fronick; Robert Fulton; Gue Su Chang; Allegra A Petti; Christopher A Miller; Timothy J Ley
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

4.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

5.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

6.  Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection.

Authors:  Megan T Baldridge; Katherine Y King; Nathan C Boles; David C Weksberg; Margaret A Goodell
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

7.  Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells.

Authors:  Thippeswamy Gulappa; Ramadevi Subramani Reddy; Suman Suman; Alice M Nyakeriga; Chendil Damodaran
Journal:  Cancer Lett       Date:  2013-05-16       Impact factor: 8.679

8.  Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling.

Authors:  Daniel Hormaechea-Agulla; Katie A Matatall; Duy T Le; Bailee Kain; Xiaochen Long; Pawel Kus; Roman Jaksik; Grant A Challen; Marek Kimmel; Katherine Y King
Journal:  Cell Stem Cell       Date:  2021-03-19       Impact factor: 25.269

9.  Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.

Authors:  Liran I Shlush; Sasan Zandi; Amanda Mitchell; Weihsu Claire Chen; Joseph M Brandwein; Vikas Gupta; James A Kennedy; Aaron D Schimmer; Andre C Schuh; Karen W Yee; Jessica L McLeod; Monica Doedens; Jessie J F Medeiros; Rene Marke; Hyeoung Joon Kim; Kwon Lee; John D McPherson; Thomas J Hudson; Andrew M K Brown; Fouad Yousif; Quang M Trinh; Lincoln D Stein; Mark D Minden; Jean C Y Wang; John E Dick
Journal:  Nature       Date:  2014-02-12       Impact factor: 69.504

10.  DNA methylation disruption reshapes the hematopoietic differentiation landscape.

Authors:  Franco Izzo; Stanley C Lee; Asaf Poran; Ronan Chaligne; Federico Gaiti; Baptiste Gross; Rekha R Murali; Sunil D Deochand; Chelston Ang; Philippa Wyndham Jones; Anna S Nam; Kyu-Tae Kim; Steven Kothen-Hill; Rafael C Schulman; Michelle Ki; Priscillia Lhoumaud; Jane A Skok; Aaron D Viny; Ross L Levine; Ephraim Kenigsberg; Omar Abdel-Wahab; Dan A Landau
Journal:  Nat Genet       Date:  2020-03-23       Impact factor: 38.330

View more
  2 in total

Review 1.  Clonal hematopoiesis: Mutation-specific adaptation to environmental change.

Authors:  Marcus A Florez; Brandon T Tran; Trisha K Wathan; James DeGregori; Eric M Pietras; Katherine Y King
Journal:  Cell Stem Cell       Date:  2022-06-02       Impact factor: 25.269

2.  Dnmt3a-Mutant Hematopoietic Stem Cell Rewire IFNγ Signaling to Gain Clonal Advantage.

Authors:  Marco De Dominici; James DeGregori
Journal:  Blood Cancer Discov       Date:  2022-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.